Accuray Incorporated Company Profile (NASDAQ:ARAY)

About Accuray Incorporated

Accuray Incorporated logoAccuray Incorporated is a radiation oncology company. The Company develops, manufactures and markets medical devices used in radiation therapy for the treatment of cancer patients. Its products include the CyberKnife Systems, the TomoTherapy Systems, and the Radixact Delivery Treatment Platform. Its technologies, the CyberKnife and TomoTherapy Systems, are designed to deliver treatments, including stereotactic radiosurgery (SRS), stereotactic body radiation therapy (SBRT), intensity modulated radiation therapy (IMRT), image guided radiation therapy (IGRT) and adaptive radiation therapy. The CyberKnife Systems are robotic systems that are used to treat various types of cancer and tumors throughout the body. The CyberKnife Systems track, detect and correct for tumor and patient movement in real-time during the procedure. The TomoTherapy Systems include the TomoTherapy H Series with configuration options of TomoH, TomoHD and TomoHDA.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Appliances & Equipment
  • Sub-Industry: Health Care Equipment
  • Exchange: NASDAQ
  • Symbol: ARAY
  • CUSIP: 00439710
Key Metrics:
  • Previous Close: $5.43
  • 50 Day Moving Average: $5.39
  • 200 Day Moving Average: $5.32
  • 52-Week Range: $82,897,000.00 - $4.45
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: -77.14
  • P/E Growth: 0.11
  • Market Cap: $451.79M
  • Outstanding Shares: 82,897,000
  • Beta: 1.58
  • Net Margins: -6.88%
  • Return on Equity: -46.38%
  • Return on Assets: -5.73%
  • Debt-to-Equity Ratio: 3.57%
  • Current Ratio: 1.76%
  • Quick Ratio: 1.11%
Additional Links:
Companies Related to Accuray Incorporated:

Analyst Ratings

Consensus Ratings for Accuray Incorporated (NASDAQ:ARAY) (?)
Ratings Breakdown: 3 Hold Ratings, 4 Buy Ratings
Consensus Rating:Buy (Score: 2.57)
Consensus Price Target: $8.33 (54.32% upside)

Analysts' Ratings History for Accuray Incorporated (NASDAQ:ARAY)
DateFirmActionRatingPrice TargetDetails
2/6/2017AegisInitiated CoverageBuy$7.00View Rating Details
2/5/2017BTIG ResearchReiterated RatingHoldView Rating Details
12/14/2016J P Morgan Chase & CoDowngradeOverweight -> Neutral$8.00 -> $6.00View Rating Details
11/7/2016Jefferies Group LLCReiterated RatingBuy$8.00View Rating Details
9/13/2016Cowen and CompanyInitiated CoverageOutperform$9.00View Rating Details
8/18/2016Morgan StanleySet Price TargetHold$8.00View Rating Details
5/22/2016Brean CapitalReiterated RatingBuy$12.00View Rating Details
1/29/2016Royal Bank of CanadaLower Price TargetSector Perform$8.00 -> $7.50View Rating Details
11/12/2015Citigroup Inc.Initiated CoverageSellView Rating Details
5/1/2015Dougherty & CoLower Price TargetBuy$10.75 -> $9.00View Rating Details
4/1/2015SidotiInitiated CoverageBuy$12.00View Rating Details
(Data available from 2/27/2015 forward)


Earnings History for Accuray Incorporated (NASDAQ:ARAY)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
1/31/2017Q217($0.09)($0.11)$93.74 million$87.50 millionViewListenView Earnings Details
10/27/2016Q117($0.10)($0.12)$37.34 million$86.50 millionViewListenView Earnings Details
8/17/2016Q316($0.07)($0.09)$98.97 million$95.00 millionViewListenView Earnings Details
4/26/2016Q316($0.06)$0.01$102.79 million$105.30 millionViewListenView Earnings Details
1/28/2016Q216($0.08)($0.08)$101.15 million$108.90 millionViewListenView Earnings Details
10/29/2015Q116($0.14)($0.12)$88.60 million$89.60 millionViewListenView Earnings Details
8/20/2015Q415($0.04)($0.07)$102.41 million$101.80 millionViewListenView Earnings Details
4/30/2015Q315($0.06)($0.04)$102.72 million$97.50 millionViewListenView Earnings Details
1/27/2015Q215($0.08)($0.13)$98.87 million$98.20 millionViewListenView Earnings Details
10/29/2014Q115($0.13)($0.28)$88.90 million$82.40 millionViewListenView Earnings Details
8/21/2014Q414($0.07)($0.13)$92.23 million$102.00 millionViewListenView Earnings Details
4/30/2014Q314($0.16)($0.06)$82.00 million$97.10 millionViewListenView Earnings Details
1/30/2014Q214($0.20)($0.07)$80.20 million$93.60 millionViewListenView Earnings Details
11/7/2013Q114($0.20)($0.21)$79.67 million$76.60 millionViewListenView Earnings Details
8/27/2013Q4 2013($0.20)($0.20)$82.29 million$84.90 millionViewListenView Earnings Details
5/7/2013Q3 2013($0.22)($0.37)$77.97 million$70.55 millionViewListenView Earnings Details
2/6/2013Q2 2013($0.33)($0.30)$74.23 million$77.80 millionViewListenView Earnings Details
11/7/2012Q113($0.22)($0.23)$85.41 million$83.00 millionViewN/AView Earnings Details
9/6/2012Q412($0.12)($0.20)$106.92 million$100.50 millionViewN/AView Earnings Details
5/8/2012($0.14)($0.21)ViewN/AView Earnings Details
11/8/2011($0.29)($0.38)ViewN/AView Earnings Details
9/19/2011$0.02($0.40)ViewN/AView Earnings Details
5/5/2011$0.04($0.02)ViewN/AView Earnings Details
1/27/2011($0.01)$0.07ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Accuray Incorporated (NASDAQ:ARAY)
Current Year EPS Consensus Estimate: $-0.19 EPS
Next Year EPS Consensus Estimate: $-0.07 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20161($0.07)($0.07)($0.07)
Q4 20161($0.08)($0.08)($0.08)
Q1 20171($0.10)($0.10)($0.10)
Q2 20171($0.06)($0.06)($0.06)
Q3 20171$0.02$0.02$0.02
Q4 20171$0.02$0.02$0.02
(Data provided by Zacks Investment Research)


Dividend History for Accuray Incorporated (NASDAQ:ARAY)
No dividend announcements for this company have been tracked by

Insider Trades

Insider Trading History for Accuray Incorporated (NASDAQ:ARAY)
Insider Ownership Percentage: 2.91%
Institutional Ownership Percentage: 91.66%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/9/2015Joshua LevineCEOBuy50,000$7.12$356,000.00View SEC Filing  
2/2/2015Alaleh NouriSVPSell5,164$7.38$38,110.32View SEC Filing  
11/30/2014Alaleh NouriSVPSell268$6.62$1,774.16View SEC Filing  
11/30/2014Kelly LondyEVPSell2,273$6.62$15,047.26View SEC Filing  
11/3/2014Joshua LevineCEOBuy100,000$6.34$634,000.00View SEC Filing  
5/6/2014Joshua LevineCEOBuy50,000$8.15$407,500.00View SEC Filing  
2/4/2014Richard PettingillDirectorBuy9,795$10.33$101,182.35View SEC Filing  
12/4/2013Jack GoldsteinDirectorSell7,000$7.70$53,900.00View SEC Filing  
12/3/2013Elizabeth DavilaDirectorSell8,000$7.74$61,920.00View SEC Filing  
9/4/2013Darren J MillikenSVPSell11,002$6.53$71,843.06View SEC Filing  
3/5/2013Dennis L WingerDirectorBuy20,000$4.30$86,000.00View SEC Filing  
2/13/2013Joshua LevineCEOBuy100,000$4.38$438,000.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Accuray Incorporated (NASDAQ:ARAY)
News IconStock Update on Earnings & Estimates for Accuray Incorporated (NASDAQ:ARAY) - Aiken Advocate (NASDAQ:ARAY) - February 27 at 8:20 AM
News IconWhat is the Sell-side Saying About Accuray Incorporated (NASDAQ:ARAY)? - Aiken Advocate (NASDAQ:ARAY) - February 25 at 3:31 PM
News IconCompany Spotlight on Shares of Accuray Incorporated (NASDAQ:ARAY) - Sherwood Daily (NASDAQ:ARAY) - February 23 at 3:38 PM logoAccuray to Present at Cowen and Company 37th Annual Healthcare Conference on March 6, 2017 (NASDAQ:ARAY) - February 21 at 8:47 AM
News IconABR Of Accuray Incorporated (NASDAQ:ARAY) Stock At 1.67 - Stock Observer (NASDAQ:ARAY) - February 19 at 8:13 AM
News IconAnalysts Weigh in on Accuray Incorporated (NASDAQ:ARAY): Consensus Notes - Rockville Register (NASDAQ:ARAY) - February 18 at 3:33 PM logoCyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients (NASDAQ:ARAY) - February 16 at 8:43 PM logoCyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients (NASDAQ:ARAY) - February 16 at 8:43 PM logoCyberKnife® System Provides Long-term Disease Control for Prostate Cancer Patients (NASDAQ:ARAY) - February 16 at 8:43 PM
News IconAccuray Incorporated (NASDAQ:ARAY) Projected to Achieve EPS Of $0.03 - Stock Observer (NASDAQ:ARAY) - February 16 at 3:41 PM
News IconImpact of Brokerage Rating on Accuray Incorporated(ARAY ... - Morning Outlook (NASDAQ:ARAY) - February 16 at 8:32 AM
News IconEPS Forecast Of Accuray Incorporated (NASDAQ:ARAY) Set At ... - Transcript Daily (NASDAQ:ARAY) - February 16 at 8:32 AM logoAccuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017 (NASDAQ:ARAY) - February 14 at 4:14 PM logoAccuray to Participate in the 2017 RBC Capital Markets Healthcare Conference on February 22, 2017 - Yahoo Finance (NASDAQ:ARAY) - February 13 at 9:04 PM
News IconBetter Buy: Intuitive Surgical, Inc. vs. Accuray Incorporated - Fox Business (NASDAQ:ARAY) - February 13 at 4:04 PM
News IconPrimecap Management Co/ca/ Picked Up Accuray Inc. (NASDAQ ... - Small Cap Exclusive (press release) (NASDAQ:ARAY) - February 13 at 4:04 PM
News IconCompany Levels in Review: Accuray Incorporated (NASDAQ:ARAY ... - Benton Bulletin (NASDAQ:ARAY) - February 11 at 3:34 PM
News IconAccuray Incorporated (NASDAQ:ARAY) Long-Term Growth Estimate At $15 - Transcript Daily (NASDAQ:ARAY) - February 11 at 3:34 PM
News IconTale of the Tape: Technical Recap for Accuray Incorporated (ARAY) - Rives Journal (NASDAQ:ARAY) - February 10 at 1:46 AM
News IconAccuray wins Japanese regulatory nod for Radixact platform (NASDAQ:ARAY) - February 9 at 8:43 PM logoACCURAY INC Financials (NASDAQ:ARAY) - February 9 at 3:41 PM logoAccuray (ARAY) Announces Receipt of Shonin Approval for Radixact System (NASDAQ:ARAY) - February 9 at 1:52 AM logoAccuray (ARAY) Announces Receipt of Shonin Approval for ... - (NASDAQ:ARAY) - February 8 at 3:50 PM logoThe Accuray Radixact™ System Receives Shonin Approval (NASDAQ:ARAY) - February 8 at 3:50 PM logoAccuray, Inc. :ARAY-US: Earnings Analysis: Q2, 2017 By the Numbers : February 7, 2017 (NASDAQ:ARAY) - February 7 at 4:32 PM logoAccuray Incorporated (NASDAQ:ARAY) EPS Projection At $0.035 - (NASDAQ:ARAY) - February 5 at 8:38 PM
News IconAccuray Incorporated | $ARAY Stock | Shares Crash Down On Lower Than Expected Q2 Earnings - Warrior Trading News (press release) (NASDAQ:ARAY) - February 3 at 3:45 PM logoAccuray Inc. Stock Shares Crash Down On Lower Than Expected Earnings (NASDAQ:ARAY) - February 3 at 2:47 AM
News IconIncrease in Volatility Draws Attention to Shares of Accuray Incorporated (NASDAQ:ARAY) - Wall Street Beacon (NASDAQ:ARAY) - February 1 at 3:43 PM logoEdited Transcript of ARAY earnings conference call or presentation 31-Jan-17 9:30pm GMT (NASDAQ:ARAY) - February 1 at 3:43 PM logoAccuray (ARAY) Incurs Wider Loss in Q2, Misses on Revenue (NASDAQ:ARAY) - February 1 at 3:43 PM
News IconAccuray shares slide on Q2 miss (NASDAQ:ARAY) - February 1 at 1:51 AM logoAccuray Incorporated : reports 2Q loss (NASDAQ:ARAY) - February 1 at 1:51 AM logoEARNINGS SUMMARY: Details of Accuray Incorporated Q2 Earnings Report (NASDAQ:ARAY) - February 1 at 1:51 AM logoAccuray Grows Second Quarter Gross Orders 17%; Backlog Up 16% YoY (NASDAQ:ARAY) - February 1 at 1:51 AM logo4:03 pm Accuray misses by $0.03, reports revs in-line; guides FY17 revs in-line (NASDAQ:ARAY) - February 1 at 1:51 AM logoAccuray's (ARAY) CEO Joshua Levine on Q2 2017 Results - Earnings Call Transcript - Seeking Alpha (NASDAQ:ARAY) - January 31 at 8:49 PM logoAccuray reports 2Q loss (NASDAQ:ARAY) - January 31 at 8:48 PM
News IconAccuray Incorporated (NASDAQ:ARAY) to Post $-0.07 Earnings Per Share: Analysts - Wall Street Beacon (NASDAQ:ARAY) - January 31 at 3:47 PM logoQ2 2017 Accuray Inc Earnings Release - After Market Close (NASDAQ:ARAY) - January 31 at 3:47 PM logoAccuray Inc Earnings Call scheduled for 4:30 pm ET today (NASDAQ:ARAY) - January 31 at 3:47 PM
News IconEPS Target Of Accuray Incorporated (NASDAQ:ARAY)Set At $0.015 - Transcript Daily (NASDAQ:ARAY) - January 30 at 9:39 PM
News IconMiami Cancer Institute treats first cancer patients with Accuray Radixact (NASDAQ:ARAY) - January 30 at 4:37 PM
News IconWhat is the Street Saying About Accuray Incorporated (NASDAQ:ARAY)? - Aiken Advocate (NASDAQ:ARAY) - January 29 at 3:34 PM
News IconChart Indicators in Focus for Accuray Incorporated (ARAY) - Rives Journal (NASDAQ:ARAY) - January 28 at 3:35 PM
News IconAccuray Incorporated (NASDAQ:ARAY) Stock ABR At 1.67 - Stock Observer (NASDAQ:ARAY) - January 28 at 3:35 PM
News IconFollowing the Numbers on Shares of Accuray Incorporated (NASDAQ:ARAY) - The Tribune (NASDAQ:ARAY) - January 27 at 9:28 PM
News IconAnalysts Take: Accuray Incorporated (NASDAQ:ARAY) Projected Earnings & Price Targets - Aiken Advocate (NASDAQ:ARAY) - January 27 at 9:28 PM logoWhy Earnings Season Could Be Great for Accuray (ARAY) - Nasdaq (NASDAQ:ARAY) - January 27 at 9:28 PM logoAccuray, Inc. breached its 50 day moving average in a Bearish Manner : ARAY-US : January 27, 2017 (NASDAQ:ARAY) - January 27 at 4:26 PM


What is Accuray Incorporated's stock symbol?

Accuray Incorporated trades on the NASDAQ under the ticker symbol "ARAY."

Where is Accuray Incorporated's stock going? Where will Accuray Incorporated's stock price be in 2017?

7 equities research analysts have issued 12-month target prices for Accuray Incorporated's shares. Their forecasts range from $6.00 to $12.00. On average, they expect Accuray Incorporated's share price to reach $8.33 in the next year.

When will Accuray Incorporated announce their earnings?

Accuray Incorporated is scheduled to release their next quarterly earnings announcement on Monday, April, 24th 2017.

What are analysts saying about Accuray Incorporated stock?

Here are some recent quotes from research analysts about Accuray Incorporated stock:

  • Aegis analysts commented, "The company has been successful in shifting gears to the smaller vault centers, re-positioning TomoTherapy as a work horse machine. Accuray has moved outside of the niche high-end large academic centers into the broader single- and dual-vault centers, with single- and dual-vault centers now accounting for 50% of new TomoTherapy orders (up from 0% in 2012).He added, "Radixact, the next-generation TomoTherapy platform, was approved for 510k in June (CE Mark in Aug) and brings ARAY up to par with Varian's TrueBeam and Elekta's Axesse machines. Radixact adds higher output dosing along with integrated treatment planning (Precision') and data management (iDMS') systems that will increase the ease and speed of systems, and should have its full launch in time for ARAYs first major replacement cycle. The reliability issues previously associated with TomoTherapy are now behind them, and Tomo is consistantly ranked #1 in overall system performance by ServiceTrak." (2/6/2017)
  • According to Zacks Investment Research, "Accuray reported wider loss in the first quarter of fiscal 2017, primarily due to declining gross orders. Of the recent developments, strong data showcasing the clinical efficacy of the CyberKnife System at the annual ASTRO Conference, several orders for the newly unveiled Radixact System and solid revenue performance in Japan are the key positives in our view. The company also witnessed strong demand for the TomoTherapy platform, which boosted the company’s growth trajectory. We believe a broad product portfolio, growing customer base, stringent cost control and international expansions will drive growth. However, a drag in the gross orders, unfavorable product mix, declining product revenues, sluggish macro economic conditions and pricing headwinds are major concerns." (11/8/2016)

Who owns Accuray Incorporated stock?

Accuray Incorporated's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Renaissance Technologies LLC (5.08%), State Street Corp (2.03%), Royce & Associates LP (1.91%), Russell Investments Group Ltd. (1.39%), Dimensional Fund Advisors LP (0.82%) and Menta Capital LLC (0.44%).

Who sold Accuray Incorporated stock? Who is selling Accuray Incorporated stock?

Accuray Incorporated's stock was sold by a variety of institutional investors in the last quarter, including Two Sigma Investments LP, Renaissance Technologies LLC, Royce & Associates LP, Metropolitan Life Insurance Co. NY and Menta Capital LLC.

Who bought Accuray Incorporated stock? Who is buying Accuray Incorporated stock?

Accuray Incorporated's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp and Dimensional Fund Advisors LP.

How do I buy Accuray Incorporated stock?

Shares of Accuray Incorporated can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Accuray Incorporated stock cost?

One share of Accuray Incorporated stock can currently be purchased for approximately $5.40.

Accuray Incorporated (NASDAQ:ARAY) Chart for Monday, February, 27, 2017

Institutional Ownership Chart

Institutional Ownership by Quarter for Accuray Incorporated (NASDAQ:ARAY)

Earnings History Chart

Earnings by Quarter for Accuray Incorporated (NASDAQ:ARAY)

Dividend History Chart

Dividend Payments by Quarter for Accuray Incorporated (NASDAQ:ARAY)

Last Updated on 2/27/2017 by Staff